|
 |
 |
|
 |
|
Lamisil (Terbinafine) Administration
Oral Administration
- May be taken with or without food.
- The optimal clinical effect in onychomycosis is seen some months after mycological cure and treatment due to the time needed for outgrowth of healthy nails.
Topical Administration
- For topical dermatologic use only; not for ophthalmic, oral, or intravaginal use.
- Wash hands before and after application. When treating hand or fingernail infections, do not wash patient’s hands after application. Use gloves if required by universal precautions.
- Rub cream, topical solution, or topical gel gently into the affected area(s). Apply an amount sufficient to cover the affected area and the immediate surrounding skin. Avoid getting in the eyes, nose, mouth, or other mucous membranes.
- Avoid occlusive dressing of the affected areas unless otherwise directed by the prescriber.
- Improvement of dermal tinea infection is gradual, and improvements in the treated condition may continue for the 2-6 weeks after terbinafine therapy is discontinued. The manufacturer recommends that patients not be considered therapeutic failures until 2-6 weeks off therapy have passed.
† non-FDA approved
Related entries
Syndicate
|
|
|
